litlas
Log inCreate account

Peter H. Wiernik

Active 1969–2021

Also published as
PETER H. WIERNIK
121
Papers
23,100
Citations
89
h-index
121
i10-index

Citations

Citations per year for Peter H. Wiernik1970: 1 citations1971: 1 citations1972: 4 citations1973: 9 citations1974: 6 citations1975: 17 citations1976: 27 citations1977: 31 citations1978: 24 citations1979: 16 citations1980: 33 citations1981: 53 citations1982: 60 citations1983: 65 citations1984: 69 citations1985: 44 citations1986: 58 citations1987: 75 citations1988: 52 citations1989: 57 citations1990: 60 citations1991: 80 citations1992: 61 citations1993: 63 citations1994: 102 citations1995: 72 citations1996: 67 citations1997: 60 citations1998: 64 citations1999: 85 citations2000: 98 citations2001: 120 citations2002: 125 citations2003: 139 citations2004: 106 citations2005: 125 citations2006: 121 citations2007: 84 citations2008: 104 citations2009: 148 citations2010: 136 citations2011: 136 citations2012: 154 citations2013: 164 citations2014: 123 citations2015: 139 citations2016: 128 citations2017: 117 citations2018: 97 citations2019: 318 citations2020: 307 citations2021: 312 citations2022: 185 citations2023: 136 citations2024: 253 citations2025: 72 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,330 citing papers, 36.2% of this breakdownItaly: 376 citing papers, 5.8% of this breakdownUnited Kingdom: 372 citing papers, 5.8% of this breakdownGermany: 353 citing papers, 5.5% of this breakdownFrance: 328 citing papers, 5.1% of this breakdownChina: 299 citing papers, 4.6% of this breakdownNetherlands: 245 citing papers, 3.8% of this breakdownCanada: 214 citing papers, 3.3% of this breakdownSpain: 193 citing papers, 3% of this breakdownJapan: 171 citing papers, 2.7% of this breakdownBelgium: 146 citing papers, 2.3% of this breakdownSwitzerland: 123 citing papers, 1.9% of this breakdown
0%36.2%Other 20%

Institutions

Fields

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Materials Science2.6%
  • Immunology and Microbiology2.4%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Health Professions0.6%
  • Other1.8%

Topics

  • Acute Myeloid Leukemia Research8.9%
  • Acute Lymphoblastic Leukemia research6.9%
  • Chronic Myeloid Leukemia Treatments3.4%
  • Cancer Treatment and Pharmacology3.3%
  • Retinoids in leukemia and cellular processes3.2%
  • Lymphoma Diagnosis and Treatment3%
  • Other71.3%

Coauthors

All papers

Open in search
  1. High Frequency and Poor Outcome of Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia in Adults

    Authors: Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Richard C. Harvey, I‐Ming Chen, Deqing Pei, Ilaria Iacobucci, Marcus B. Valentine, Stanley Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, Alessandro Rambaldi, Manuela Tosi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Peter H. Wiernik, Ravi Bhatia, Ibrahim Aldoss, Jessica Kohlschmidt, Krzysztof Mrózek, Guido Marcucci, Clara D. Bloomfield, Wendy Stock, Stephen Kornblau, Hagop M. Kantarjian, Marina Konopleva, Elisabeth Paietta, Cheryl L. Willman, Charles G. Mullighan - Journal of Clinical Oncology 2017 cited by 449

  2. Very poor long‐term survival in past and more recent studies for relapsed AML patients: The ECOG‐ACRIN experience

    Authors: Chezi Ganzel, Zhuoxin Sun, Larry D. Cripe, Hugo F. Fernández, Dan Douer, Jacob M. Rowe, Elisabeth Paietta, Rhett P. Ketterling, Michael J. O’Connell, Peter H. Wiernik, John M. Bennett, Mark R. Litzow, Selina M. Luger, Hillard M. Lazarus, Martin S. Tallman - American Journal of Hematology 2018 cited by 156

  3. Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALL

    Authors: Elisabeth Paietta, Kathryn G. Roberts, Victoria Wang, Zhaohui Gu, Georgina Buck, Deqing Pei, Cheng Cheng, Ross L. Levine, Omar Abdel‐Wahab, Zhongshan Cheng, Gang Wu, Chunxu Qu, Lei Shi, Stanley Pounds, Cheryl L. Willman, Richard C. Harvey, Janis Racevskis, Jan Bařinka, Yanming Zhang, Gordon W. Dewald, Rhett P. Ketterling, David Alejos, Hillard M. Lazarus, Selina M. Luger, Letizia Foroni, Bela Patel, Adele K. Fielding, Ari Melnick, David I. Marks, Anthony V. Moorman, Peter H. Wiernik, Jacob M. Rowe, Martin S. Tallman, Anthony H. Goldstone, Charles G. Mullighan, Mark R. Litzow - Blood 2021 cited by 116

  4. All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

    Authors: Martin S. Tallman, Janet W. Andersen, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, Lois E. Shepherd, Cheryl L. Willman, Clara D. Bloomfield, Jacob M. Rowe, Peter H. Wiernik - New England Journal of Medicine 1997 cited by 1,093

  5. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

    Authors: Anthony V. Moorman, Christine J. Harrison, Georgina Buck, Sue Richards, Lorna M. Secker‐Walker, Mary Martineau, Gail H. Vance, Athena M. Cherry, Rodney R. Higgins, Adele K. Fielding, Letizia Foroni, Elisabeth Paietta, Martin S. Tallman, Mark R. Litzow, Peter H. Wiernik, Jacob M. Rowe, Anthony H. Goldstone, Gordon W. Dewald - Blood 2006 cited by 748

  6. Hypersensitivity reactions from taxol.

    Authors: R B Weiss, Ross C. Donehower, Peter H. Wiernik, T Ohnuma, R. Gralla, D L Trump, James R. Baker, David A. Van Echo, Daniel D. Von Hoff, B Leyland-Jones - Journal of Clinical Oncology 1990 cited by 1,177

  7. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

    Authors: Anthony H. Goldstone, Susan Richards, Hillard M. Lazarus, Martin S. Tallman, Georgina Buck, Adele K. Fielding, Alan K. Burnett, Raj Chopra, Peter H. Wiernik, Letizia Foroni, Elisabeth Paietta, Mark R. Litzow, David I. Marks, Jill Durrant, Andrew McMillan, Ian M. Franklin, Selina M. Luger, Niculae Ciobanu, Jacob M. Rowe - Blood 2007 cited by 782

  8. ETV6 mutations in early immature human T cell leukemias

    Authors: Pieter Van Vlierberghe, Alberto Ambesi‐Impiombato, Arianne Pérez-García, J. Erika Haydu, Isaura Rigo, Michael Hadler, Valeria Tosello, Giusy Della Gatta, Elisabeth Paietta, Janis Racevskis, Peter H. Wiernik, Selina M. Luger, Jacob M. Rowe, Montserrat Rué, Adolfo A. Ferrando - The Journal of Experimental Medicine 2011 cited by 211

  9. The role of carbonic anhydrase IX overexpression in kidney cancer

    Authors: Thambi Dorai, Ihor S. Sawczuk, Jaromı́r Pastorek, Peter H. Wiernik, Janice P. Dutcher - European Journal of Cancer 2005 cited by 164

  10. Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

    Authors: Simon Mantha, Debra A. Goldman, Sean M. Devlin, Ju-Whei Lee, Diana Zannino, Marnie Collins, Dan Douer, Harry Iland, Mark R. Litzow, Eytan M. Stein, Frederick R. Appelbaum, Richard A. Larson, Richard M. Stone, Bayard L. Powell, Susan Geyer, Kristina Laumann, Jacob M. Rowe, Harry P. Erba, Steven Coutré, Megan Othus, Jae H. Park, Peter H. Wiernik, Martin S. Tallman - Blood 2017 cited by 125

  11. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD

    Authors: David Steiger, Maria Siddiqi, Rowena Yip, David F. Yankelevitz, Claudia I. Henschke, Claudia I. Henschke, David F. Yankelevitz, Rowena Yip, Artit Jirapatnakul, Raja M. Flores, Andrea Wolf, Daniel M. Libby, James P. Smith, Mark Pasmantier, Anthony P. Reeves, Steven Markowitz, Albert Miller, José Cervera Deval, Heidi Roberts, Demetris Patsios, Shusuke Sone, Takaomi Hanaoka, Javier J. Zulueta, Juan P. de‐Torres, María D. Lozano, Ralph W. Aye, Kristin Manning, Thomas Bauer, Stefano Canitano, Salvatore Giunta, Enser Cole, Karl Klingler, John H. M. Austin, Gregory D. Pearson, Dorith Shaham, Cheryl Aylesworth, Patrick Meyers, Shahriyour Andaz, Davood Vafai, David P. Naidich, Georgeann McGuinness, Barry Sheppard, Matthew D. Rifkin, M. Kristin Thorsen, Richard M. Hansen, Samuel Kopel, William Mayfield, Dan W. Luedke, Donald Klippenstein, Alan Litwin, Peter Loud, Leslie J. Kohman, Ernest M. Scalzetti, Richard J. Thurer, Nestor Villamizar, Arfa Khan, Rakesh Shah, Xueguo Liu, Gary Herzog, Diana Yeh, Ning Wu, J. Lowry, Mary Salvatore, Carmine Frumiento, David S. Mendelson, Michael V. Smith, Robert J. Korst, Jana Taylor, Michelle S. Ginsberg, Michaela Straznicka, Mark Widmann, G Cecchi, Terence A.S. Matalon, Paul Scheinberg, Shari-Lynn Odzer, David K. Olsen, Fred Grannis, Arnold Rotter, Daniel Ray, David Mullen, Peter H. Wiernik, Edson H. Cheung, Melissa Lim, Louis DeCunzo, Robert Glassberg, Harvey I. Pass, Carmen Endress, Mark Yoder, Palmi Shah, Laura S. Welch, Michael Kalafer, Jeremy Green, James Walsh, David Bertsch, Elmer Camacho, Cynthia Chin, James P. O’Brien, James C. Willey - Clinical Imaging 2021 cited by 40

  12. Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia

    Authors: Marissa Rashkovan, Robert Albero, Francesca Gianni, Pablo Perez-Duran, Hannah I. Miller, Adam L. Mackey, Elisabeth M. Paietta, Martin S. Tallman, Jacob M. Rowe, Mark R. Litzow, Peter H. Wiernik, Selina Luger, Maria Luisa Sulis, Rajesh K. Soni, Adolfo A. Ferrando - Cancer Discovery 2021 cited by 40

  13. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

    Authors: KR Rai, JF Holland, O Glidewell, V Weinberg, K Brunner, JP Obrecht, HD Preisler, IW Nawabi, D Prager, RW Carey, MR Cooper, F Haurani, J. L. Hutchison, RT Silver, G Falkson, Peter H. Wiernik, HC Hoagland, CD Bloomfield, G. Watson James, A. Gottlieb, SV Ramanan, J Blom, Nissen Ni, A Bank, RR Ellison, F Kung, P Henry, O. Ross McIntyre, SK Kaan - Blood 1981 cited by 418

  14. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia

    Authors: Ilaria Iacobucci, Yongjin Li, Kathryn G. Roberts, Stephanie M. Dobson, Jaeseung Kim, Debbie Payne-Turner, Richard C. Harvey, Marcus Valentine, Kelly McCastlain, John Easton, Donald Yergeau, Laura J. Janke, Ying Shao, I-Ming L. Chen, Michael Rusch, Sasan Zandi, Steven M. Kornblau, Marina Konopleva, Elias Jabbour, Elisabeth Paietta, Jacob M. Rowe, Ching‐Hon Pui, Julie M. Gastier‐Foster, Zhaohui Gu, Shalini C. Reshmi, Mignon L. Loh, Janis Racevskis, Martin S. Tallman, Peter H. Wiernik, Mark R. Litzow, Cheryl L. Willman, John D. McPherson, James R. Downing, Jinghui Zhang, John E. Dick, Stephen P. Hunger, Charles G. Mullighan - Cancer Cell 2016 cited by 144

  15. PHF6 mutations in T-cell acute lymphoblastic leukemia

    Authors: Pieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, Joni Van der Meulen, Mireia Castillo-Martín, Nadine Van Roy, Barbara De Moerloose, Jan Philippé, Sara González-García, Marı́a L. Toribio, Tom Taghon, Linda Zuurbier, Barbara Cauwelier, Christine J. Harrison, Claire Schwab, Markus Pisecker, Sabine Strehl, Anton W. Langerak, Jozef Gécz, Edwin Sonneveld, Rob Pieters, Elisabeth Paietta, Jacob M. Rowe, Peter H. Wiernik, Yves Benoît, Jean Soulier, Bruce Poppe, Xiaopan Yao, Carlos Cordon‐Cardo, Jules P.P. Meijerink, Raúl Rabadán, Frank Speleman, Adolfo A. Ferrando - Nature Genetics 2010 cited by 312

  16. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia

    Authors: Peter H. Wiernik - Expert Opinion on Investigational Drugs 2016 cited by 88

  17. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

    Authors: Jeffrey Schriber, Parameswaran Hari, Kwang Woo Ahn, Mingwei Fei, Luciano J. Costa, M A Kharfan-Dabaja, Miguel Angel-Diaz, Robert Peter Gale, Siddharatha Ganguly, Saulius Girnius, Shahrukh K. Hashmi, Attaphol Pawarode, David H. Vesole, Peter H. Wiernik, Baldeep Wirk, David I. Marks, Taiga Nishihori, Richard F. Olsson, Saad Z. Usmani, Tomer M. Mark, Yago Nieto, Anita D’Souza - Cancer 2017 cited by 87

  18. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm

    Authors: Rowena Yip, Teng Ma, Raja M. Flores, David F. Yankelevitz, Claudia I. Henschke, Claudia I. Henschke, David F. Yankelevitz, Rowena Yip, Mary Salvatore, Raja M. Flores, Andrea Wolf, Mildred Chen, Daniel M. Libby, James P. Smith, Mark Pasmantier, Anthony P. Reeves, Steven Markowitz, Albert Miller, José Cervera Deval, Heidi Roberts, Demetris Patsios, Shusuke Sone, Takaomi Hanaoka, Javier J. Zulueta, Juan P. de‐Torres, María D. Lozano, Ralph W. Aye, Kristin Manning, Thomas Bauer, Stefano Canitano, Salvatore Giunta, Enser Cole, Karl Klingler, John H. M. Austin, Gregory D. Pearson, Dorith Shaham, Cheryl Aylesworth, Patrick Meyers, Shahriyour Andaz, Davood Vafai, David P. Naidich, Georgeann McGuinness, Barry Sheppard, Matthew D. Rifkin, M. Kristin Thorsen, Richard M. Hansen, Samuel Kopel, William Mayfield, Dan W. Luedke, Donald Klippenstein, Alan Litwin, Peter Loud, Leslie J. Kohman, Ernest M. Scalzetti, Richard J. Thurer, Nestor Villamizar, Arfa Khan, Rakesh Shah, Xueguo Liu, Gary Herzog, Diana Yeh, Ning Wu, J. Lowry, Mary Salvatore, Carmine Frumiento, David S. Mendelson, Michael V. Smith, Robert J. Korst, Jana Taylor, Michelle S. Ginsberg, Michaela Straznicka, Mark Widmann, G Cecchi, Terence A.S. Matalon, Paul Scheinberg, Shari-Lynn Odzer, David K. Olsen, Fred Grannis, Arnold Rotter, Daniel Ray, David Mullen, Peter H. Wiernik, Edson H. Cheung, Melissa Lim, Louis DeCunzo, Robert Glassberg, Harvey I. Pass, Carmen Endress, Mark Yoder, Palmi Shah, Laura S. Welch, Michael Kalafer, Jeremy Green, James Walsh, David Bertsch, Elmer Camacho, Cynthia Chin, James P. O’Brien, James C. Willey - Journal of Thoracic Oncology 2019 cited by 38

  19. Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993

    Authors: Adele K. Fielding, Jacob M. Rowe, Susan Richards, Georgina Buck, Anthony V. Moorman, Ian Durrant, David I. Marks, Andrew McMillan, Mark R. Litzow, Hillard M. Lazarus, Letizia Foroni, Gordon W. Dewald, Ian M. Franklin, Selina M. Luger, Elisabeth Paietta, Peter H. Wiernik, Martin S. Tallman, Anthony H. Goldstone - Blood 2009 cited by 288

  20. Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Authors: Sonali M. Smith, Linda J. Burns, Koen van Besien, Jennifer Le‐Rademacher, Wensheng He, Timothy S. Fenske, Ritsuro Suzuki, Jack W. Hsu, Harry C. Schouten, Gregory A. Hale, Leona Holmberg, Anna Sureda, César O. Freytes, Richard T. Maziarz, David J. Inwards, Robert Peter Gale, Thomas G. Gross, Mitchell S. Cairo, Luciano J. Costa, Hillard M. Lazarus, Peter H. Wiernik, Dipnarine Maharaj, Ginna G. Laport, Silvia Montoto, Parameswaran Hari - Journal of Clinical Oncology 2013 cited by 230

  21. Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008

    Authors: Chezi Ganzel, Judith Manola, Dan Douer, Jacob M. Rowe, Hugo F. Fernández, Elisabeth Paietta, Mark R. Litzow, Ju-Whei Lee, Selina M. Luger, Hillard M. Lazarus, Larry D. Cripe, Peter H. Wiernik, Martin S. Tallman - Journal of Clinical Oncology 2016 cited by 133

  22. Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease

    Authors: Veronika Bachanová, D I Marks, M-J Zhang, Hai‐Lin Wang, Marcos de Lima, Mahmoud Aljurf, Martha Arellano, Andrew Artz, Ulrike Bacher, J-Y Cahn, Y-B Chen, Edward A. Copelan, William R. Drobyski, Robert Peter Gale, John P. Greer, Vikas Gupta, Gregory A. Hale, Partow Kebriaei, Hillard M. Lazarus, Ian D. Lewis, Victor Lewis, Jane L. Liesveld, Mark R. Litzow, Alison W. Loren, Alan M. Miller, Maxim Norkin, Betül Oran, Joseph Pidala, Jacob M. Rowe, Bipin N. Savani, Wael Saber, Ravi Vij, Edmund K. Waller, Peter H. Wiernik, Daniel J. Weisdorf - Leukemia 2013 cited by 135

  23. Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

    Authors: Mary Jo Lechowicz, Hillard M. Lazarus, Joaquim Carreras, Ginna G. Laport, Corey Cutler, Peter H. Wiernik, Gregory A. Hale, Dipnarine Maharaj, Robert Peter Gale, Philip A. Rowlings, César O. Freytes, Alan M. Miller, Julie M. Vose, Richard T. Maziarz, Silvia Montoto, DG Maloney, Parameswaran Hari - Bone Marrow Transplantation 2014 cited by 105

  24. Long-Term Progression-Free Survival of Patients with Metastatic Melanoma or Renal Cell Carcinoma following High-Dose Interleukin-2

    Authors: Joseph I. Clark, Brendan D. Curti, Elizabeth J. Davis, Howard L. Kaufman, Asim Amin, Ajjai Alva, Theodore F. Logan, Ralph J. Hauke, Gerald Miletello, Ulka N. Vaishampayan, Douglas B. Johnson, Richard L. White, Peter H. Wiernik, Janice P. Dutcher - Journal of Investigative Medicine 2021 cited by 22